| 2021-12-10 | Chu Yu-Waye | Senior VP Clinical Development | Sale+OE | 7,500 | $51.46 | $385,947.94 | -0.8% | → |
| 2021-11-18 | Wolchko J Scott | President and CEO | Sale+OE | 20,000 | $54.27 | $1,085,400.00 | -4.8% | → |
| 2021-10-22 | Wolchko J Scott | President and CEO | Sale+OE | 60,000 | $59.55 | $3,572,959.65 | -4.8% | → |
| 2021-10-01 | TAHL CINDY | General Counsel and Secretary | Sale+OE | 50,000 | $58.83 | $2,941,461.99 | -11.9% | → |
| 2021-09-28 | Dulac Edward J III | Chief Financial Officer | Sale+OE | 19,460 | $62.53 | $1,216,833.80 | -27.1% | → |
| 2021-09-13 | Valamehr Bahram | Chief Development Officer | Sale+OE | 25,000 | $66.29 | $1,657,257.42 | -7.8% | → |
| 2021-08-19 | Wolchko J Scott | President and CEO | Sale+OE | 20,000 | $88.01 | $1,760,204.00 | -4.8% | → |
| 2021-08-19 | Dulac Edward J III | Chief Financial Officer | Sell | 3,474 | $88.26 | $306,602.40 | -2.1% | → |
| 2021-07-23 | Wolchko J Scott | President and CEO | Sale+OE | 60,000 | $85.67 | $5,140,113.38 | -3.6% | → |
| 2021-07-01 | TAHL CINDY | General Counsel and Secretary | Sale+OE | 55,534 | $85.24 | $4,733,743.28 | -3.1% | → |
| 2021-06-14 | Valamehr Bahram | Chief Development Officer | Sale+OE | 25,000 | $89.32 | $2,233,045.21 | -7.8% | → |
| 2021-05-20 | Wolchko J Scott | President and CEO | Sale+OE | 20,000 | $77.16 | $1,543,292.00 | -4.8% | → |
| 2021-04-23 | Wolchko J Scott | President and CEO | Sale+OE | 60,000 | $85.39 | $5,123,496.00 | -7.1% | → |
| 2021-04-16 | Chu Yu-Waye | Senior VP Clinical Development | Sell | 3,275 | $83.30 | $272,809.00 | -1.6% | → |
| 2021-04-01 | TAHL CINDY | See Remarks | Sale+OE | 18,466 | $82.50 | $1,523,390.63 | -3.6% | → |